PARK INNOVARE

News

Six candidates to join the Swiss BIC of CERN Technologies incubation program

The Swiss Business Incubation Centre (BIC) of CERN Technologies entrepreneurship program is going to Phase II. Out of nearly 20 candidates from Switzerland...

Mehr Informationen Mehr Informationen

DER PARK INNOVAARE SICHERT DIE FINANZIERUNG DES NEUEN CAMPUS

Der PARK INNOVAARE ist ein Innovationspark neben dem Paul Scherrer Institut PSI und seinem einzigartigen Komplex von Grossforschungsanlagen. Er bietet...

Mehr Informationen

4. ordentliche Generalversammlung der innovAARE AG

Der PARK INNOVAARE markiert einen weiteren wichtigen Meilenstein in seiner Entwicklung: Die Finanzierung der Realisierung des neuen Campus ist nun gesichert....

Mehr Informationen

Dr. Fabia Gozzo: an exceptional, creative, inventive, and innovative woman and entrepreneur

(This information is only available in English) In a couple of weeks, London will welcome some of the world’s most innovative women from all sectors...

Mehr Informationen

Novel Accelerators for Electron Diffraction workshop at PARK INNOVAARE

Understanding how matter creates life requires observing living cells with atomic detail. There are many ways to do so, but one possibility has been gaining...

Mehr Informationen

WE ARE HIRING!

PARK INNIVAARE is an innovation park next to the Paul Scherrer Institute PSI. It offers academic spin-offs, innovative start-ups, SMEs and big companies,...

Mehr Informationen

A platform to discuss high-level topics with the pharmaceutical industry

(This information is only available in English) Novartis (Switzerland) and Alphora (Canada) joined the case study program conducted as part of the Second...

Mehr Informationen

BIC of CERN Technologies calls for innovative ideas leveraging accelerator technologies

As of today, start-ups and spin-offs, as well as small high-tech companies, younger than two years, can apply to become the next Business Incubation Centre...

Mehr Informationen

InterAx partners with Lundbeck to identify better pharmaceutical compounds

InterAx Biotech AG, a spin-off of the Paul Scherrer Institute PSI and ETH Zurich, based at PARK INNOVAARE, is building a proprietary systems biology platform...

Mehr Informationen

Excelsus invites pharma companies to explore for free the possibilities of synchrotron X-ray powder diffraction

The second annual Spring Pharmaceutical Synchrotron X-Ray Powder Diffraction (SPS-XRPD-2) Workshop, organized together with the 16th Pharmaceutical Powder...

Mehr Informationen

InterAx raises CHF 3 Mio for the commercialization of its systems biology platform

InterAx Biotech AG is a spin off from the ETH Zürich and Paul Scherrer Institute (PSI). The company assists GPCR drug candidate design and selection by...

Mehr Informationen

Two well-known techniques + new application field = breakthrough of the year

This fall, Dr. Tim Grüne from the Paul Scherrer Institute (PSI) together with Crystallise! AG published the results of their joint project, presenting...

Mehr Informationen
1 2 3 4 5 6 7 8